HealthCo Healthcare and Wellness REIT (ASX:HCW)
Australia flag Australia · Delayed Price · Currency is AUD
0.6800
+0.0100 (1.49%)
Jun 5, 2026, 4:10 PM AEST

ASX:HCW Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, ASX:HCW stock has a consensus rating of "Buy" and an average price target of $0.85. The average 1-year stock price forecast is 25.00% higher than the current stock price, while the lowest is $0.70 (+2.94%) and the highest is $1.00 (+47.06%).

Price Target: $0.85 (+25.00%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$0.70$0.85$0.84$1.00
Change+2.94%+25.00%+23.53%+47.06%
* Price targets were last updated on Apr 21, 2026.

Analyst Ratings

The average analyst rating for ASX:HCW stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy122233
Buy111111
Hold312211
Sell000000
Strong Sell111111
Total656666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Sell
Maintains
$0.73$0.70
SellMaintains$0.73$0.70+2.94%Apr 21, 2026
Macquarie
Macquarie
Hold
Maintains
$0.67
HoldMaintains$0.67-1.47%Apr 7, 2026
Morgans
Morgans
Buy
Maintains
$1.05$0.85
BuyMaintains$1.05$0.85+25.00%Mar 24, 2026
Jefferies
Jefferies
Hold
Maintains
$0.75
HoldMaintains$0.75+10.29%Feb 18, 2026
Bell Potter
Bell Potter
Buy
Maintains
$1.00$0.95
BuyMaintains$1.00$0.95+39.71%Feb 18, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
56.47M
from 60.40M
Decreased by -6.50%
Revenue Next Year
55.75M
from 56.47M
Decreased by -1.27%
EPS This Year
0.04
from -0.02
EPS Next Year
0.06
from 0.04
Increased by 33.37%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingJun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026
Revenue
31.75M47.70M72.00M60.40M56.47M
Revenue Growth
-50.26%50.94%-16.11%-6.50%
Net Income
54.11M20.20M6.90M-88.80M-54.60M
EPS
----0.020.04
Dividend / Share
0.080.080.080.04-
Dividend Growth
--6.81%4.92%-47.50%-100.00%
Free Cash Flow
-45.23M19.60M9.66M99.00M
FFO
17.89M25.50M45.30M36.50M24.40M
FFO / Share
----0.04
P/FFO
----15.55
No. Analysts
----4
EPS based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue202620272028
High60.0M
Avg56.5M
Low53.0M

Revenue Growth

Revenue Growth202620272028
High
-0.6%
Avg
-6.5%
Low
-12.3%

EPS Forecast

EPS202620272028
High-
Avg0.04
Low-

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-